Hearing threshold in patients with chronic renal failure

Akeem O Lasisi1, Babatunde L Salako, Mohammed A Kodiya

  • 1Department of Otorhinolaryngology, College of Medicine, University of Ibadan, Ibadan, PO Box 22040, Nigeria.sakeemng@yahoo.com

Saudi Medical Journal
|April 26, 2007
PubMed

Insights

Sensorineural hearing loss is prevalent in chronic renal failure (CRF) patients and correlates with disease duration. Regular hearing tests are recommended for CRF patients to monitor auditory health.

Area of Science:

  • Nephrology
  • Audiology
  • Otorhinolaryngology

Background:

  • Chronic renal failure (CRF) is a significant health concern with potential multi-organ complications.
  • Auditory dysfunction, specifically hearing loss, is an under-recognized complication in patients with CRF.

Purpose of the Study:

  • To investigate the prevalence and pattern of hearing loss in patients suffering from chronic renal failure (CRF).
  • To explore potential correlations between hearing loss and clinical parameters in CRF patients.

Main Methods:

  • A case-control study involving 33 CRF patients and 28 healthy controls.
  • Pure tone audiometry was performed to assess hearing thresholds.
  • Data on age, gender, duration of illness, blood pressure, and creatinine levels were collected and analyzed.

Main Results:

  • Sensorineural hearing loss was significantly more common in CRF patients (67%) compared to controls (32%).
  • A significant correlation was found between the duration of renal disease and hearing threshold (p=0.00387, r=0.73).
  • No significant correlation was observed between hearing threshold and diastolic blood pressure, diuretic dosage, or creatinine levels.

Conclusions:

  • Sensorineural hearing loss is a frequent complication in patients with chronic renal failure.
  • The duration of CRF is a significant factor associated with the severity of hearing loss.
  • Routine audiological assessments should be integrated into the comprehensive care of CRF patients.
Abstract

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...